Nuveen’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.72M | Buy |
485,458
+330,021
| +212% | +$4.62M | ﹤0.01% | 1777 |
|
|
2026
Q1 | $1.46M | Sell |
155,437
-30,696
| -16% | -$337K | ﹤0.01% | 2393 |
|
|
2025
Q4 | $2.31M | Sell |
186,133
-14,710
| -7% | -$196K | ﹤0.01% | 2229 |
|
|
2025
Q3 | $2.88M | Sell |
200,843
-110
| -0.1% | -$1.51K | ﹤0.01% | 2148 |
|
|
2025
Q2 | $2.47M | Sell |
200,953
-31,789
| -14% | -$462K | ﹤0.01% | 2214 |
|
|
2025
Q1 | $5.12M | Buy |
232,742
+48,367
| +26% | +$1.14M | ﹤0.01% | 1919 |
|
|
2024
Q4 | $4.18M | Sell |
184,375
-67,698
| -27% | -$1.48M | ﹤0.01% | 2066 |
|
|
2024
Q3 | $4.58M | Sell |
252,073
-241,646
| -49% | -$5.6M | ﹤0.01% | 2031 |
|
|
2024
Q2 | $14.4M | Buy |
493,719
+322,904
| +189% | +$9.58M | ﹤0.01% | 1346 |
|
|
2024
Q1 | $6.06M | Sell |
170,815
-442
| -0.3% | -$17.7K | ﹤0.01% | 1877 |
|
|
2023
Q4 | $7.46M | Buy |
171,257
+40,260
| +31% | +$1.58M | ﹤0.01% | 1764 |
|
|
2023
Q3 | $5M | Sell |
130,997
-48,611
| -27% | -$2.05M | ﹤0.01% | 1867 |
|
|
2023
Q2 | $7.39M | Sell |
179,608
-11,842
| -6% | -$570K | ﹤0.01% | 1687 |
|
|
2023
Q1 | $11M | Sell |
191,450
-41,959
| -18% | -$2.36M | ﹤0.01% | 1421 |
|
|
2022
Q4 | $13.1M | Sell |
233,409
-7,314
| -3% | -$372K | 0.01% | 1317 |
|
|
2022
Q3 | $10.2M | Buy |
240,723
+5,584
| +2% | +$286K | ﹤0.01% | 1459 |
|
|
2022
Q2 | $12.7M | Buy |
235,139
+84,859
| +56% | +$5.1M | ﹤0.01% | 1359 |
|
|
2022
Q1 | $9.71M | Buy |
150,280
+87
| +0.1% | +$5.73K | ﹤0.01% | 1661 |
|
|
2021
Q4 | $10.1M | Buy |
150,193
+11,641
| +8% | +$788K | ﹤0.01% | 1690 |
|
|
2021
Q3 | $9.49M | Sell |
138,552
-5,008
| -3% | -$354K | ﹤0.01% | 1819 |
|
|
2021
Q2 | $9.8M | Buy |
143,560
+6,656
| +5% | +$471K | ﹤0.01% | 1884 |
|
|
2021
Q1 | $9.46M | Sell |
136,904
-5,170
| -4% | -$350K | ﹤0.01% | 1833 |
|
|
2020
Q4 | $9.22M | Buy |
142,074
+718
| +0.5% | +$38.6K | ﹤0.01% | 1760 |
|
|
2020
Q3 | $6.67M | Sell |
141,356
-13,958
| -9% | -$664K | ﹤0.01% | 1765 |
|
|
2020
Q2 | $7.3M | Sell |
155,314
-41,740
| -21% | -$2.05M | ﹤0.01% | 1692 |
|
|
2020
Q1 | $8.8M | Sell |
197,054
-71,792
| -27% | -$3.77M | ﹤0.01% | 1373 |
|
|
2019
Q4 | $15.7M | Buy |
268,846
+5,410
| +2% | +$322K | 0.01% | 1311 |
|
|
2019
Q3 | $15.8M | Buy |
263,436
+101,345
| +63% | +$6.04M | 0.01% | 1282 |
|
|
2019
Q2 | $9.05M | Buy |
+162,091
| New | +$8.35M | ﹤0.01% | 1666 |
|
|
2018
Q1 | – | Sell |
-24,205
| Closed | -$1.16M | – | 1103 |
|
|
2017
Q4 | $1.16M | Buy |
24,205
+3,836
| +19% | +$188K | 0.01% | 709 |
|
|
2017
Q3 | $1.03M | Buy |
+20,369
| New | +$1.05M | 0.01% | 757 |
|
|
2016
Q4 | – | Sell |
-28,232
| Closed | -$1.17M | – | 1554 |
|
|
2016
Q3 | $1.17M | Sell |
28,232
-16,494
| -37% | -$691K | 0.01% | 1023 |
|
|
2016
Q2 | $1.78M | Sell |
44,726
-16,226
| -27% | -$584K | 0.01% | 794 |
|
|
2016
Q1 | $2.05M | Sell |
60,952
-13,882
| -19% | -$432K | 0.01% | 733 |
|
|
2015
Q4 | $2.54M | Sell |
74,834
-26,122
| -26% | -$816K | 0.01% | 675 |
|
|
2015
Q3 | $3.01M | Sell |
100,956
-22,672
| -18% | -$709K | 0.02% | 618 |
|
|
2015
Q2 | $3.4M | Sell |
123,628
-21,027
| -15% | -$560K | 0.02% | 618 |
|
|
2015
Q1 | $3.65M | Sell |
144,655
-1,470
| -1% | -$34.7K | 0.02% | 606 |
|
|
2014
Q4 | $3.24M | Sell |
146,125
-45,749
| -24% | -$928K | 0.02% | 663 |
|
|
2014
Q3 | $3.89M | Sell |
191,874
-97,360
| -34% | -$1.94M | 0.02% | 611 |
|
|
2014
Q2 | $5.56M | Sell |
289,234
-7,699
| -3% | -$143K | 0.03% | 526 |
|
|
2014
Q1 | $5.58M | Sell |
296,933
-33,189
| -10% | -$640K | 0.03% | 502 |
|
|
2013
Q4 | $6.44M | Sell |
330,122
-85,837
| -21% | -$1.57M | 0.04% | 468 |
|
|
2013
Q3 | $6.84M | Sell |
415,959
-21,326
| -5% | -$342K | 0.04% | 452 |
|
|
2013
Q2 | $5.62M | Buy |
+437,285
| New | +$6.41M | 0.04% | 475 |
|
Other funds holding IART
RCMNY
PCMI
Nuveen's IART Position: Q2 2026 in Review
Nuveen increased its Integra LifeSciences (IART) stake by 212% in Q2 2026, buying an estimated $4.62M and bringing the position to 485,458 shares worth $8.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1777.
Nuveen first reported a position in IART in Q2 2013 and has held it in 45 quarters since. The position peaked at $15.8M in Q3 2019. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- Nuveen held 485,458 shares of Integra LifeSciences worth $8.72M as of Q2 2026.
- Nuveen bought 330,021 Integra LifeSciences shares in Q2 2026, an estimated $4.62M.
- Integra LifeSciences made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1777 holding.
- Nuveen first reported a position in Integra LifeSciences in Q2 2013 and has held it in 45 quarters since.
- Nuveen's Integra LifeSciences position peaked at $15.8M in Q3 2019.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.